Perrigo Company plc $PRGO Shares Purchased by CenterBook Partners LP

Posted by George Bondi on Jun 8th, 2026

CenterBook Partners LP lifted its position in Perrigo Company plc (NYSE:PRGO – Free Report) by 211.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 573,644 shares of the company’s stock after purchasing an additional 389,492 shares during the quarter. CenterBook Partners LP owned approximately 0.42% of Perrigo worth $7,985,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the company. Vanguard Group Inc. boosted its position in shares of Perrigo by 7.9% in the 4th quarter. Vanguard Group Inc. now owns 14,983,369 shares of the company’s stock valued at $208,568,000 after purchasing an additional 1,101,154 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of Perrigo by 2.4% in the 3rd quarter. Dimensional Fund Advisors LP now owns 7,695,238 shares of the company’s stock valued at $171,367,000 after purchasing an additional 181,828 shares during the period. State Street Corp boosted its position in shares of Perrigo by 9.5% in the 2nd quarter. State Street Corp now owns 7,340,323 shares of the company’s stock valued at $196,134,000 after purchasing an additional 637,678 shares during the period. Thompson Siegel & Walmsley LLC boosted its position in shares of Perrigo by 28.4% in the 4th quarter. Thompson Siegel & Walmsley LLC now owns 4,658,601 shares of the company’s stock valued at $64,848,000 after purchasing an additional 1,029,770 shares during the period. Finally, Ion Asset Management Ltd. boosted its position in shares of Perrigo by 34.7% in the 2nd quarter. Ion Asset Management Ltd. now owns 3,817,621 shares of the company’s stock valued at $102,007,000 after purchasing an additional 983,727 shares during the period. 95.91% of the stock is owned by institutional investors and hedge funds.

Perrigo Stock Performance

Shares of PRGO stock opened at $10.85 on Monday. The stock has a market capitalization of $1.50 billion, a PE ratio of -0.83, a price-to-earnings-growth ratio of 1.28 and a beta of 0.51. Perrigo Company plc has a 52-week low of $9.23 and a 52-week high of $28.43. The stock’s 50-day moving average price is $11.07 and its 200 day moving average price is $12.51. The company has a quick ratio of 1.59, a current ratio of 2.72 and a debt-to-equity ratio of 1.45.

Perrigo (NYSE:PRGO – Get Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.04. The firm had revenue of $841.80 million for the quarter, compared to analysts’ expectations of $1.04 billion. Perrigo had a positive return on equity of 9.96% and a negative net margin of 43.50%.The firm’s revenue for the quarter was down 7.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.60 EPS. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. As a group, equities research analysts forecast that Perrigo Company plc will post 2.12 EPS for the current year.

Perrigo Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 16th. Investors of record on Friday, May 29th will be given a $0.29 dividend. This represents a $1.16 annualized dividend and a yield of 10.7%. The ex-dividend date is Friday, May 29th. Perrigo’s payout ratio is -8.85%.

Analysts Set New Price Targets

A number of brokerages recently issued reports on PRGO. Zacks Research raised Perrigo from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Canaccord Genuity Group decreased their target price on Perrigo from $20.00 to $17.00 and set a “buy” rating for the company in a research report on Friday, February 27th. Weiss Ratings cut Perrigo from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, May 28th. Finally, Jefferies Financial Group restated a “hold” rating on shares of Perrigo in a research report on Thursday, February 26th. One research analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Perrigo currently has a consensus rating of “Hold” and an average target price of $19.33.

Check Out Our Latest Stock Report on Perrigo

Perrigo Company Profile

(Free Report)

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.